These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28489482)

  • 1. Real world prescription trends of methotrexate for psoriasis in Argentina: results of a national survey.
    Mazzuoccolo LD; Luna PC; Marciano S; Castro Perez GA; Marchesi C; Nocito MJ; Martin Koller V; Lorenzo J; Koch C; Echeverria CM
    J Dermatolog Treat; 2017 Nov; 28(7):631-634. PubMed ID: 28489482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA.
    Al-Dabagh A; Davis SA; Kinney MA; Huang K; Feldman SR
    Am J Clin Dermatol; 2013 Jun; 14(3):155-61. PubMed ID: 23575550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current practice of methotrexate use for psoriasis: results of a worldwide survey among dermatologists.
    Gyulai R; Bagot M; Griffiths CEM; Luger T; Naldi L; Paul C; Puig L; Kemény L
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):224-231. PubMed ID: 24731093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
    Berends MA; de Jong EM; van de Kerkhof PC; Gerritsen MJ
    Dermatology; 2007; 215(1):45-52. PubMed ID: 17587839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis.
    Zargari O; Hejazi S; Shahidi-Dadras M; Younespour S; Robati R; Firooz A; Toosi P; Feldman SR
    Int J Dermatol; 2014 Mar; 53(3):385-9. PubMed ID: 24134730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S; Krishna V; Kanwar AJ
    Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines.
    Busger Op Vollenbroek FTM; Doggen CJM; Janssens RWA; Bernelot Moens HJ
    PLoS One; 2018; 13(3):e0194401. PubMed ID: 29570708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.
    Haustein UF; Rytter M
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):382-8. PubMed ID: 11305380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J; Simková M; Vanecková J; Hroch M; Chládkova J; Martínková J; Vávrová J; Beránek M
    Eur J Clin Pharmacol; 2008 Apr; 64(4):347-55. PubMed ID: 18163165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and safety of Methotrexate in psoriasis: an eight-year experience with 218 patients.
    Cabello Zurita C; Grau Pérez M; Hernández Fernández CP; González Quesada A; Valerón Almazán P; Vilar Alejo J; Carretero Hernández G
    J Dermatolog Treat; 2017 Aug; 28(5):401-405. PubMed ID: 28001499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate in erythrocytes of patients with psoriasis.
    Schrøder H; Foged EK
    Eur J Clin Pharmacol; 1986; 30(4):453-6. PubMed ID: 3743621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A; Tan E; Ilchyshyn A; Berth-Jones J
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of severe psoriasis. A national survey.
    Peckham PE; Weinstein GD; McCullough JL
    Arch Dermatol; 1987 Oct; 123(10):1303-7. PubMed ID: 3662561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologists' views and opinions about photo(chemo)therapy and conventional systemic psoriasis therapies: results from a Belgian survey.
    Nijsten T; Lambert J
    Dermatology; 2006; 213(2):123-33. PubMed ID: 16902289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate for psoriasis: current European practice. A postal survey.
    Boffa MJ
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):196-202. PubMed ID: 15752290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Subcutaneous methotrexate in psoriasis and psoriatic arthritis treatment].
    Szczerkowska-Dobosz A
    Wiad Lek; 2016; 69(4):675-679. PubMed ID: 27941209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD; Leman J; Balasubramaniam P; Macfarlane AW; Al-Niaimi F; Griffiths CE; Burden AD; Warren RB
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study.
    Strober BE; Poulin Y; Kerdel FA; Langley RG; Gu Y; Gupta SR; Okun MM; Papp KA
    J Am Acad Dermatol; 2011 Apr; 64(4):671-81. PubMed ID: 21414495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.